# CORE SYSTEM — Stage 8 Implementation Record

**Date:** 2026-08-29  
**Stage:** 8 — Global Search  
**Status:** **CLOSED — PRODUCTION READY**

## Official scope

Stage 8 is the Global Search stage defined by `docs/GLOBAL-UX-IA-IMPLEMENTATION-PLAN-2026-08-28-FINAL.md`.

The approved requirement is a genuine system-wide search surface available from a clear and consistent location, searching authorized information across Domains while respecting tenant isolation, permissions, privacy, Arabic/English behavior, and direct navigation to the appropriate record.

## Implementation and reconciliation

Global Search was implemented on the existing Workspace shell. Existing Supabase server access, effective-permission resolution, canonical Domain tables, tenant boundaries, and the canonical i18n system were reused.

No parallel Patient Journey, Queue, authorization, entitlement, workspace, or registry architecture was created. No Stage 8 database migration was required.

Search coverage includes Patients, Staff, Invoices, Appointments, Treatment Plans, Services/Procedures, Inventory, Suppliers, Purchase Orders, and Patient Portal communication context.

UI visibility and server-side authorization are both permission-aware; search queries are tenant-scoped and do not use a service-role client. No Sidebar item was added; Global Search is a Workspace-shell surface.

## Engineering validation — PASS

The validated application lineage passed the Stage 8 engineering gates:

- lockfile synchronization
- `npm ci`
- production dependency audit diagnostic
- TypeScript
- I18N audit
- I18N parity
- Stage 5 Widget audit
- Stage 5 Domain Surface audit
- Stage 6 Patient Flow audit
- Stage 7 Patient Context audit
- Stage 8 Global Search audit
- Stage 8 changed-surface ESLint
- production build

The final production candidate commit `88559c4db32f32e2a074ad735ea97538e62171bf` has successful Vercel deployment status.

## Production verification — PASS

Production deployment:

- **Vercel deployment:** `dpl_Hh9uJkAywQHn1Xe9gDd1SbdoLzVh`
- **Deployment state:** READY
- **Production aliases:** `core-system-clinic.vercel.app` and the existing main-branch aliases
- **Deployment commit SHA:** `88559c4db32f32e2a074ad735ea97538e62171bf`
- **Production `/` response:** HTTP 200; unauthenticated access correctly resolves to the existing `/login` surface.
- **Production runtime logs:** no logs/errors reported for the final deployment verification window.
- **GitHub Vercel status for the production candidate:** SUCCESS.

The available runtime verification confirms the production deployment is serving the validated application. Authenticated search authorization and tenant-isolation behavior are additionally enforced by the server action and dedicated Stage 8 audit; no new credential or secret was required.

## Findings disposition

**S8-F-001 — Deferred, non-blocking.** Staff/procedure results currently target the closest existing canonical administrative surface because dedicated detail routes are not part of the current navigation authority. Owner: AJM / Tenant Administration and Medical Master Library. This does not justify creating parallel routes in Stage 8.

**S8-F-002 — Resolved.** Earlier Vercel provider rate-limit behavior affected a preview deployment path. The final production Git-integration candidate subsequently reached READY for the validated production SHA. No workaround or repository secret was introduced.

## Definition of Done / Production Readiness

- Official scope implemented: PASS
- Architecture reconciliation: PASS
- AJM/PJ reconciliation: PASS
- Authorization / tenant scoping: PASS
- Database state: PASS — no migration required; canonical production schema reused
- GitHub engineering validation: PASS
- Production build: PASS
- Stage 8 audit: PASS
- Regression audits for Stages 5–7: PASS
- Production deployment: PASS
- Runtime verification: PASS for available production surface/log evidence
- Stage 8 blocker: NONE
- Documentation: COMPLETE
- Final repository re-check: COMPLETE for the closure candidate

## Closure

**Stage 8 — CLOSED.**  
**Production Ready — YES.**

The deferred S8-F-001 is explicitly retained as future cross-workstream work and is not a Stage 8 blocker.
